When compared to controls, acromegaly patients had significantly lower sclerostin levels, after adjustments for age and BMI (adjusted β = −36.0 ± 8.1, p < 0.001), with comparable results for both sexes (Fig. 2). Here, SOST is linked to acromegaly.